£520.00

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States

Price data last checked 35 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 56 days · 56 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 April 2026 09 May 2026 23 May 2026 06 June 2026 20 June 2026

Price Distribution

Price distribution over 56 days • 1 price levels

Days at Price
56 days 0 14 28 42 56 £520 Days at Price

Price Analysis

Most common price: £520 (56 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 56 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in Japan
99% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in Japan

£495.00 16 Jun 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments for US Zip Codes
98% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments for US Zip Codes

£490.00 20 Jun 2026
The 2023-2028 Outlook for Macular Degeneration Treatments in the United States
98% match

The 2023-2028 Outlook for Macular Degeneration Treatments in the United States

£520.00 21 Jun 2026
The 2023-2028 Outlook for Macular Degeneration Treatments in India
98% match

The 2023-2028 Outlook for Macular Degeneration Treatments in India

£515.00 20 Jun 2026
The 2023-2028 Outlook for Uveitis Drugs in India
98% match

The 2023-2028 Outlook for Uveitis Drugs in India

£515.00 23 Jun 2026
The 2026-2031 World Outlook for Diabetic Macular Edema
97% match

The 2026-2031 World Outlook for Diabetic Macular Edema

£885.00 25 Jun 2026
Early Events in Diabetic Retinopathy and Intervention Strategies
97% match

Early Events in Diabetic Retinopathy and Intervention Strategies

IntechOpen

£119.00 14 Jul 2026
The 2023-2028 Outlook for Dry Eye Syndrome Treatments in the United States
97% match

The 2023-2028 Outlook for Dry Eye Syndrome Treatments in the United States

£520.00 19 Jun 2026
Humana Diabetic Retinopathy: Methods and Protocols 2678 Book
97% match

Humana Diabetic Retinopathy: Methods and Protocols 2678 Book

Humana

£106.00 15 Jul 2026
Pathobiology of Diabetic Retinopathy: Diabetes, Diabetic Retinopathy and Medicinal Plants
97% match

Pathobiology of Diabetic Retinopathy: Diabetes, Diabetic Retinopathy and Medicinal Plants

LAP Lambert Academic Publishing

£66.00 08 Jul 2026
The 2023-2028 Outlook for Dry Eye Syndrome Treatments in India
97% match

The 2023-2028 Outlook for Dry Eye Syndrome Treatments in India

£515.00 19 Jun 2026
Diabetic Retinopathy: A Glance At Molecular Level: Gene polymorphisms, Antioxidant status, Potential biomarkers and Risk factors
97% match

Diabetic Retinopathy: A Glance At Molecular Level: Gene polymorphisms, Antioxidant status, Potential biomarkers and Risk factors

LAP Lambert Academic Publishing

£64.00 09 Jul 2026
The 2023-2028 Outlook for Eye Drops in India
97% match

The 2023-2028 Outlook for Eye Drops in India

£515.00 20 Jun 2026
The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema in the United States
97% match

The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema in the United States

£520.00 16 Jul 2026
Therapeutic Targets for Diabetic Retinopathy: A Translational Approach
97% match

Therapeutic Targets for Diabetic Retinopathy: A Translational Approach

Elsevier

£39.49 04 Jul 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
97% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

£520.00 17 Jun 2026
The 2025-2030 World Outlook for Diabetic Macular Edema
97% match

The 2025-2030 World Outlook for Diabetic Macular Edema

Price unavailable
IntechOpen Diabetic Retinopathy - Medical Healthcare Book
97% match

IntechOpen Diabetic Retinopathy - Medical Healthcare Book

IntechOpen

£139.00 15 Jul 2026
The 2023-2028 Outlook for Diabetes Care Products in the United States
97% match

The 2023-2028 Outlook for Diabetes Care Products in the United States

£520.00 20 Jun 2026
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in India
97% match

The 2023-2028 Outlook for Myopia and Presbyopia Treatments in India

£515.00 19 Jun 2026
The 2023-2028 Outlook for Vision Care in India
97% match

The 2023-2028 Outlook for Vision Care in India

£515.00 17 Jun 2026
The 2023-2028 Outlook for 4K Display Resolution Technologies in the United States
97% match

The 2023-2028 Outlook for 4K Display Resolution Technologies in the United States

£520.00 25 Jun 2026
The 2027-2032 World Outlook for Dry Eye Syndrome Treatments
97% match

The 2027-2032 World Outlook for Dry Eye Syndrome Treatments

£890.00 13 Jul 2026
The 2023-2028 Outlook for Optical Goods and Eye Care Products in the United States
97% match

The 2023-2028 Outlook for Optical Goods and Eye Care Products in the United States

£520.00 19 Jun 2026